The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence

İDİLMAN, RAMAZAN; AKYILDIZ, MURAT; KESKİN, ONUR; güngör, gökhan; yılmaz, tonguç; KALKAN, ÇAĞDAŞ; DAYANGAÇ, MURAT; ÇINAR, KUBİLAY; BALCI, DENİZ; HAZİNEDAROĞLU, SELÇUK; tokat, yaman

doi:10.1111/ctr.12804

The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence

İDİLMAN R., AKYILDIZ M., KESKİN O., güngör g., yılmaz t. u., KALKAN Ç., ...Daha Fazla

CLINICAL TRANSPLANTATION, cilt.30, sa.10, ss.1216-1221, 2016 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 30 Sayı: 10
Basım Tarihi: 2016
Doi Numarası: 10.1111/ctr.12804
Dergi Adı: CLINICAL TRANSPLANTATION
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1216-1221
Hacettepe Üniversitesi Adresli: Hayır

Özet

BackgroundThe aim of this study was to determine the long-term efficacy of nucleos(t)ide analog (NA) and low-dose hepatitis B immunoglobulin (HBIG) combination treatment for preventing post-transplant hepatitis B virus (HBV) recurrence.